The FDA has granted Fast Track designation to PP-01 for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.

Preclinical data previously published in the peer-reviewed journal, The Journal of Pain,1 demonstrate robust antinociceptive effects of AV-101, similar to gabapentin, but with a better side effect ...

The patent will not expire until at least 2034 and is part of Vistagen’s global patent portfolio on manufacturing methods and therapeutic uses for AV-101 to treat various disorders involving the NMDA ...

He prescribed me Gabapentin, thus this thread. My GP also agreed that Gaba is the first drug she would prescribe for nerve pain. Hard to say if they're working, but I'm optimistic. If you think you're ...